Navigation Links
Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
Date:5/11/2009

- Conference Call Today at 4:30 p.m. Eastern Time -

SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today reported on its corporate progress and financial results for the first quarter ended March 31, 2009.

"We continue to make significant progress with both of our product candidates -- Dimebon in patients with Alzheimer's and Huntington's diseases and MDV3100 in patients with prostate cancer. Having received written permission from the FDA to initiate a pivotal Phase 3 trial of MDV3100 in castration-resistant prostate cancer, we are on track to be in Phase 3 testing in all of our clinical programs this year," said David Hung, M.D., president and chief executive officer of Medivation. "We expect to achieve a significant milestone in June - completion of enrollment in our six-month, confirmatory, pivotal Phase 3 CONNECTION trial in mild-to-moderate Alzheimer's disease. And as part of our plan to support a broad and differentiated label for Dimebon in Alzheimer's disease, we are pleased to have initiated the Phase 3 CONCERT trial of Dimebon in combination with donepezil (Aricept(R)), and intend to begin two additional Phase 3 trials in moderate-to-severe Alzheimer's disease patients this year."

Recent Highlights and Accomplishments

Dimebon

  • Expect to complete patient enrollment in CONNECTION, a confirmatory, pivotal Phase 3 trial in patients with mild-to-moderate Alzheimer's disease, in June.
  • Initiated the Phase 3 CONCERT trial in patients with mild-to-moderate Alzheimer's disease; the 12-month clinical trial is designed to evaluate the efficacy of Dimebon when added to ongoing treatment with donepezil (Aricept(R)), the leading Alzheimer's disease medication worldwide, and builds on
    '/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
2. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
3. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
4. Medivation Announces Participation in Upcoming Conferences
5. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
8. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
9. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Results from a large observational study reported ... is superior to heparin in the absence ... in patients with non-ST segment elevation acute ... (PCI)., European and US NSTE-ACS guidelines currently ... unfractionated heparin plus GP IIb/IIIa receptor inhibitors ...
(Date:5/22/2013)... NY (PRWEB) May 22, 2013 ... an exclusive partnership with Aurora Financial Systems, Inc. ... tool to companies that offer Medicare Advantage Health ... members for completing 3 out of 12 preferred ... product launched March 2013, and provides an incentive ...
(Date:5/22/2013)... MA (PRWEB) May 22, 2013 In ... hit the country’s fields and courts with donated ... Sports, a Massachusetts-based nonprofit dedicated to partnering with manufacturers ... is celebrating the donation of $8.8 million in sports ... more than a half-million kids outfitted for physical activity. ...
(Date:5/22/2013)... York City, New York (PRWEB) May 22, 2013 ... American: Causes, Culture, Consequences, and Cost ” article published recently ... obesity is fully justified. The Centers for Disease Control ... U.S. adults aged 20 and over are overweight, 35.7% are ... facts are highlighted in this investigative article. In particular, the ...
(Date:5/22/2013)... 2013 Following the success of last ... Fit Body Boot Camp Kincardine has announced it ... Challenge starting on June 3rd at its Kincardine ... Street, Kincardine, Ontario.     , Fit Body Boot Camp’s 1,000 ... local community residents to lose a total of 1,000 ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Integrated Printing Solutions and Aurora Financial Systems, Inc. Create Partnership for Healthcare Incentive Card 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 2Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3
... ... inflammatory bowel disease (IBD) research were awarded the Crohn,s & Colitis Foundation,s prestigious ... & Research Conference ( http://www.advancesinibd.com/ ) in Hollywood, Florida on December 4th. ... New ...
... , , ... a new market research report is available in ... strategic assessment of the competitive environment is widely ... responsibilities, the task crucial to business survival, growth ...
... 17 Good Samaritan Hospital is changing the way women manage ... Good Samaritan Hospital Women,s Center For Bladder & Pelvic Health. , ... - lack of bladder control (urinary incontinence) and slippage of the ... women report some degree of urinary leakage and one out of ...
... 2009 Canadian teenagers are among the largest consumers ... drug on young brains are worse than originally thought, ... psychiatric researcher from the Research Institute of the McGill ... Neurobiology of Disease , suggests that daily consumption of ...
... particle might someday ease accompanying lung infections , THURSDAY, Dec. ... infected with the swine flu virus, and researchers say they,ve ... the severity of the illness appears to be a molecule ... off germs and disease. Researchers who analyzed levels of the ...
... ... examinations underscore the important role that competent, educated CT technologists play in minimizing ... , ... NM (Vocus) December 16, 2009 -- Two recent studies examining radiation doses delivered ...
Cached Medicine News:Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 2Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 3Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 4Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 5Health News:Reportlinker Adds Top Ten World's Leading Life Science Intermediates Companies 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4
(Date:5/22/2013)... N.J. , May 22, 2013  BD (Becton, ... leading global medical technology company, announced today the publication ... BD,s fifth Sustainability Report and it continues to focus ... "We believe the principles of shared value ... addressing healthcare challenges of societies — are fundamental to ...
(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...
(Date:5/22/2013)... May 22, 2013 Elbit Imaging ... today, further to the Company,s announcement dated May 9, ... Tel Aviv District Court (the ... shareholders for the approval of the proposed restructuring of ... of arrangement (the "Arrangement") under Section 350 of the ...
Breaking Medicine Technology:BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
... A drug to treat inflammation plays a surprising role reducing ... deadly for AIDS and cancer patients and others with weakened immune ... rid of the fungal evaders by enhancing the body,s ability to ... lungs, where it would continue to provoke an onslaught of harmful ...
... Inc., the leader in examination and minor surgery lighting ... improved reach, and better range of mobility in an ... five times more bright white illuminance than similar lights ... light provides illuminance of 30,000 lux at 18 inches. ...
Cached Medicine Technology:Old Drug Holds Promise Against Opportunistic Lung Bug 2Old Drug Holds Promise Against Opportunistic Lung Bug 3Old Drug Holds Promise Against Opportunistic Lung Bug 4
... The Summit SI Spinal Fixation ... for rigid posterior fixation of ... spine. The simplicity and versatility ... optimize the construct based on ...
OctaFix is designed specifically to provide stability and fixation where it is most needed....
...
...
Medicine Products: